AB-2004 in Treatment of Irritability Associated With Autism Spectrum

See also
Status	Clinical Trial	Phase
Terminated	`NCT03715166` - Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder	Phase 3
Not yet recruiting	`NCT05182697` - SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)	N/A
Completed	`NCT02803801` - Build Your Parenting Toolkit: Guiding Children to Become Flexible Thinkers	N/A
Recruiting	`NCT04376151` - Guided ACT and for Adults With ASD	N/A
Terminated	`NCT03715153` - Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.	Phase 3
Terminated	`NCT01592773` - Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)	Phase 2
Withdrawn	`NCT01395953` - Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders	Phase 2
Terminated	`NCT01248130` - Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders	Phase 2
Completed	`NCT04860986` - A Repeatability and Reproducibility Study of the EarliPoint™ Device
Completed	`NCT04299464` - A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)	Phase 2
Recruiting	`NCT03392870` - Evaluation of a Clinical Transitional Program in Autism	N/A
Completed	`NCT01592786` - An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)	Phase 2
Enrolling by invitation	`NCT05187377` - A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism	Phase 2
Completed	`NCT04631432` - Choice Switching and Autism
Recruiting	`NCT04578756` - Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder	Phase 3
Recruiting	`NCT06443320` - Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders	N/A
Completed	`NCT02037022` - Pivotal Response Treatment Package for Young Children With Autism	N/A
Completed	`NCT01854346` - Social Skills Group Training ("KONTAKT") for Children and Adolescent With High-functioning Autism Spectrum Disorders	N/A
Active, not recruiting	`NCT03426826` - The Gut-Brain Study	Phase 1
Completed	`NCT02384486` - Efficacy of Training Programme to Reduce Stress	N/A

NCT number	NCT04895215
Study type	Interventional
Source	Axial Therapeutics, Inc.
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	August 2, 2021
Completion date	December 2023

AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms